Business Context and Reporting Period
This Form 6-K filing by ProQR Therapeutics N.V. reports the results of the Annual General Meeting of Shareholders held on June 23, 2020. The filing was submitted on June 24, 2020, and covers corporate governance actions and shareholder approvals rather than operational or financial performance for a specific fiscal period.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the outcomes of shareholder votes regarding corporate governance and board appointments.
Material Changes
There are no material financial changes reported in this document. The primary changes involve corporate structure and governance approvals, including the adoption of 2019 annual accounts and the re-appointment of board members.
Guidance, Outlook, and Governance Actions
Shareholders approved the following key agenda items:
- Financial Approval: Adoption of annual accounts for the financial year 2019.
- Board Releases: Release from liability for both the Management Board and Supervisory Board regarding 2019 performance.
- Board Appointments: Re-appointment of Supervisory Board members Dinko Valerio and James Shannon.
- Auditor: Appointment of KPMG Accountants N.V. as the external auditor for the 2021 financial year.
- Compensation and Equity: Approval of amendments to the Equity Incentive Plan, Supervisory Board compensation principles, and Management Board compensation policy.
- Capital Actions: Authorization for the Management Board to issue and acquire ordinary shares.
Key Facts for Investor Verification
- Verify the full text of the 2019 Annual Report to review the financial accounts approved by shareholders.
- Confirm the specific terms of the amended Equity Incentive Plan and compensation policies.
- Monitor future filings for details on the issuance or acquisition of ordinary shares authorized by the Management Board.
- Note that KPMG Accountants N.V. is the designated auditor for the 2021 fiscal year.